Recent advances in cancer research have underscored the critical role of myeloid cells in shaping tumor microenvironments ...

Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells ...

After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...

Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells ...

A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

撰文丨王聪编辑丨王多鱼排版丨水成文癌症是一组异质性疾病，其特征是恶性细胞不受控制地生长和扩散，逃脱了正常的检查和平衡机制。肿瘤的分子特征可用于临床干预，以实现个性化治疗。癌症基因组图谱（TCGA）和国际癌症基因组联盟（ICGC）的大规模基因组学研究旨 ...

当通过静脉注射给药时，卡介苗会重新编程骨髓中的造血干细胞/祖细胞（HSPC），从而对感染产生异源性保护作用。但目前尚不清楚膀胱内给药卡介苗的抗肿瘤作用是否与其对 HSPC 的重编程有关。

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

When facing a cancer diagnosis, the usual treatment modalities are surgery, chemotherapy, or radiation therapy. But what if there was another powerful weapon in the fight against cancer you haven’t ...

三十多年前，美国FDA批准卡介苗（BCG）作为首个抗癌免疫疗法。时至今日，卡介苗仍用于早期膀胱癌的治疗。近日，来自威尔康奈尔医学院和纪念斯隆凯特琳癌症中心的研究团队正在深入探索这种疗法的作用机制，以便提高免疫疗法的整体治疗效果。